Cabergoline associated with first episode mania.
Division of Endocrinology and Metabolism, North Shore-LIJ Health System, Lake Success, NY, USA.
Yael T
YT
Harris
Alexander Z
AZ
Harris
Jose M
JM
Deasis
Stephen J
SJ
Ferrando
Nirmala
N
Reddy
Robert C
RC
Young
D000568:Amenorrhea / Q000188:drug therapy* / Q000209:etiology; D001714:Bipolar Disorder / Q000139:chemically induced* / Q000188:drug therapy / Q000523:psychology; D000077465:Cabergoline; D003987:Dibenzothiazepines / Q000008:administration & dosage / Q000627:therapeutic use; D004198:Disease Susceptibility; D018491:Dopamine Agonists / Q000009:adverse effects / Q000494:pharmacology*; D004359:Drug Therapy, Combination; D004873:Ergolines / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006966:Hyperprolactinemia / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D000069348:Quetiapine Fumarate; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use; D014635:Valproic Acid / Q000008:administration & dosage / Q000627:therapeutic use
D003987:Dibenzothiazepines; D018491:Dopamine Agonists; D004873:Ergolines; D014149:Tranquilizing Agents; D000069348:Quetiapine Fumarate; D014635:Valproic Acid; D000077465:Cabergoline